《大行報告》里昂料阿里(09988.HK)上季經調整EBITA按年跌30%至291億人民幣
里昂發表研究報告指,阿里巴巴(09988.HK)(BABA.US)業務在4月至5月份嚴格疫情封控中受到嚴重影響,該行預期截至6月底止季度收入將按年下跌1%至2,038億元人民幣,當中客戶管理收入(CMR)預期下跌12%,經調整EBITA則按年跌30%至291億元人民幣。
惟里昂指出,中國各地陸續重新開放,阿里表現有望復甦,預計今年下半年CMR將回升至中高單位數增幅;由於基數較低及成本控制,預期第三財季EBITA將實現增長。
該行調低2023至2025年淨利潤預測約2.5%,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.